Heart and Lung Transplantation

Heart and Lung Transplantation is a highly advanced cardiothoracic subspecialty focused on replacing failing cardiac and pulmonary organs to restore life-sustaining function. As a distinguished theme within a global Surgery Conference, this session examines complex operative techniques, donor-recipient coordination, and long-term outcomes in cardiopulmonary transplantation surgery. With end-stage heart and lung diseases continuing to pose significant global health challenges, transplantation remains a definitive therapeutic option for carefully selected patients.

The transplantation process begins with meticulous patient evaluation, including assessment of disease severity, comorbidities, and psychosocial readiness. Advanced heart failure, pulmonary hypertension, cystic fibrosis, and chronic obstructive pulmonary disease are among the common indications. Surgical planning requires precise donor organ matching, preservation techniques, and timing coordination to ensure optimal graft viability. Intraoperative management involves cardiopulmonary bypass support and detailed vascular anastomosis to restore circulation and oxygenation.

Heart transplantation focuses on replacing the diseased myocardium while maintaining hemodynamic stability and minimizing ischemic time. Lung transplantation, whether single or bilateral, demands careful airway and vascular reconstruction. In certain complex cases, combined heart-lung transplantation may be necessary. Postoperative management is equally critical, with immunosuppressive therapy, infection surveillance, and rejection monitoring forming the backbone of long-term success.

Technological innovations such as ex vivo organ perfusion systems have expanded donor organ utilization by preserving and assessing graft function before implantation. Enhanced imaging and hemodynamic monitoring improve intraoperative precision and postoperative care. Multidisciplinary collaboration among transplant surgeons, cardiologists, pulmonologists, anesthesiologists, and transplant coordinators ensures comprehensive patient management.

This session also addresses ethical considerations, allocation policies, and long-term survivorship challenges including chronic rejection and graft vasculopathy. Advances in regenerative medicine, xenotransplantation research, and artificial organ support systems continue to shape the future landscape of transplant surgery. By integrating surgical expertise with immunologic science and critical care excellence, heart and lung transplantation remains one of the most transformative achievements in modern surgical medicine.